4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Lexicon Pharmaceuticals, Inc. (LXRX) operates in the Biotechnology industry and is headquartered in The Woodlands, United States with about 81 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, LXRX reported $50M in revenue and ($50M) in net income.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease.
Interactive charts & full statements → Open the LXRX valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $50M | $31M | $1M | $0M | — |
| Gross Profit | $50M | $30M | $1M | $0M | — |
| Operating Income (EBIT) | ($49M) | ($197M) | ($172M) | ($101M) | — |
| Net Income | ($50M) | ($200M) | ($177M) | ($102M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $21M | $6M | $14M | $29M | $1M |
| Gross Profit | $21M | $5M | $14M | $29M | $1M |
| Operating Income (EBIT) | ($1M) | ($15M) | ($12M) | $4M | ($26M) |
| Net Income | ($1M) | ($16M) | ($13M) | $3M | ($25M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $185M | $298M | $229M | $194M | — |
| Total Liabilities | $77M | $152M | $136M | $77M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LXRX viewer.
About TickerBase · Data methodology & sources